Correlation Between Oric Pharmaceuticals and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oric Pharmaceuticals and Atea Pharmaceuticals, you can compare the effects of market volatilities on Oric Pharmaceuticals and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Atea Pharmaceuticals.
Diversification Opportunities for Oric Pharmaceuticals and Atea Pharmaceuticals
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Oric and Atea is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Oric Pharmaceuticals and Atea Pharmaceuticals
Given the investment horizon of 90 days Oric Pharmaceuticals is expected to under-perform the Atea Pharmaceuticals. In addition to that, Oric Pharmaceuticals is 1.01 times more volatile than Atea Pharmaceuticals. It trades about -0.23 of its total potential returns per unit of risk. Atea Pharmaceuticals is currently generating about 0.0 per unit of volatility. If you would invest 330.00 in Atea Pharmaceuticals on September 27, 2024 and sell it today you would lose (5.00) from holding Atea Pharmaceuticals or give up 1.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oric Pharmaceuticals vs. Atea Pharmaceuticals
Performance |
| Timeline |
| Oric Pharmaceuticals |
| Atea Pharmaceuticals |
Oric Pharmaceuticals and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oric Pharmaceuticals and Atea Pharmaceuticals
The main advantage of trading using opposite Oric Pharmaceuticals and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.| Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
| Atea Pharmaceuticals vs. Oric Pharmaceuticals | Atea Pharmaceuticals vs. Lyra Therapeutics | Atea Pharmaceuticals vs. Inhibrx | Atea Pharmaceuticals vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |